An2 Therapeutics, Inc. · NASDAQ:ANTX
Trenor Cameron C. III received 116,667 An2 Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 15, 2026 · Filed Sep 16, 2026
On Sep 15, 2026, Trenor Cameron C. III (Chief Medical Officer) received 116,667 An2 Therapeutics, Inc. shares as an award, leaving 116,667 shares. Filed Sep 16, 2026 (Form 4).
- Awarded
- 116,667 shares
- Holding after
- 116,667 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Award | 116,667 | 116,667 | Direct |